Macdronic 5mg/100ml Solution

A healthcare professional administers it over at least 15 minutes in a clinical setting.

Macdronic 5mg/100ml Solution Ingredients and Usage

Macdronic 5mg/100ml Solution contains zoledronic acid, a nitrogen containing bisphosphonate belonging to the antiresorptive drug class. Doctors prescribe it for the treatment and prevention of osteoporosis in postmenopausal women, given as a single infusion once a year.

Macdronic 5mg/100ml Solution also treats Paget's disease of bone, a condition where bone breaks down and rebuilds abnormally, causing pain and deformity. It may additionally be used for osteoporosis linked to long-term corticosteroid use, under specialist guidance.

How Does Macdronic 5mg/100ml Solution Work?

Zoledronic acid binds to bone mineral and inhibits osteoclasts, the specialized cells responsible for breaking down bone tissue. By slowing this bone resorption process, it allows bone formation to outpace breakdown.

This shift increases bone mineral density over time and reduces the risk of vertebral and hip fractures in osteoporosis. In Paget's disease, Macdronic 5mg/100ml Solution normalizes the abnormally fast bone turnover that causes pain and structural weakness.

Macdronic 5mg/100ml Solution Side Effects

Macdronic 5mg/100ml Solution commonly causes flu-like symptoms after the first infusion, known as an acute phase reaction. These symptoms usually ease with subsequent doses.

• Fever and chills within 1 to 3 days of infusion

• Bone, joint, or muscle pain

• Headache

• Fatigue

• Nausea and vomiting

• Low calcium or phosphate levels

• Swelling in the lower legs or feet

Warnings

• Macdronic 5mg/100ml Solution can cause osteonecrosis of the jaw; a dental exam is recommended before starting treatment, and invasive dental procedures should be avoided during therapy.

• Atypical femur fractures have been reported with long-term use; report new or unusual thigh, hip, or groin pain to a doctor promptly.

• The medicine can cause kidney toxicity, including acute renal failure in rare cases; adequate hydration before infusion and kidney function monitoring are required.

• Patients must be adequately supplemented with calcium and vitamin D throughout treatment to prevent worsening hypocalcemia.

• Avoid use in patients with severe renal impairment, and do not exceed the recommended dose in patients with reduced kidney function.

• Serious allergic reactions, including anaphylaxis and severe skin reactions, have been reported; seek immediate care for swelling, difficulty breathing, or widespread rash.

• Use with caution in pregnancy and breastfeeding, since zoledronic acid can remain in bone tissue for an extended period after treatment.

Macdronic 5mg/100ml Solution Storage Conditions

Store Macdronic 5mg/100ml Solution at room temperature between 15°C and 30°C. Keep the bottle in its original packaging until immediately before use, and avoid freezing. Store this medicine out of reach of children and ensure only trained healthcare staff handle preparation and administration.